An increase in the expression of KLF4, ABCG2, and ABCB1 was associated with resistance to paclitaxel in head and neck squamous cell carcinoma (HNSCC), according to research by Duz et al. [28]. This evidence concerns the gene ABCB1 and head and neck squamous cell carcinoma.